Keywords: b-ms, nears, start, ca4p, trials, bristol-myers, squibb

B-MS nears start of CA4P trials

Article | 30 November 2000

Print This

Bristol-Myers Squibb has filed for approval to start US clinicaltrials of its combretastatin A4 prodrug, a vascular targeting agent developed ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in